γ-Catenin-Dependent Signals Maintain BCR-ABL1+ B Cell Acute Lymphoblastic Leukemia

被引：20

作者：

Luong-Gardiol, Noemie ^{[1
,8
]}

Siddiqui, Imran ^{[1
]}

Pizzitola, Irene ^{[1
]}

Jeevan-Raj, Beena ^{[1
]}

Charmoy, Melanie ^{[1
]}

Huang, Yun ^{[2
,3
]}

Irmisch, Anja ^{[4
,9
]}

Curtet, Sara ^{[1
]}

Angelov, Georgi S. ^{[1
]}

Danilo, Maxime ^{[1
,10
]}

Juilland, Melanie ^{[5
]}

Bornhauser, Beat ^{[2
,3
]}

Thome, Margot ^{[5
]}

Hantschel, Oliver ^{[4
]}

Chalandon, Yves ^{[6
]}

Cazzaniga, Gianni ^{[7
]}

Bourquin, Jean-Pierre ^{[2
,3
]}

Huelsken, Joerg ^{[4
]}

Held, Werner ^{[1
]}

机构：

[1] Univ Lausanne, Dept Oncol UNIL CHUV, Epalinges, Switzerland

[2] Univ Childrens Hosp Zurich, Dept Pediat Oncol, Zurich, Switzerland

[3] Univ Childrens Hosp Zurich, Childrens Res Ctr, Zurich, Switzerland

[4] Fed Univ Technol Lausanne EPFL, Swiss Inst Expt Canc Res ISREC, Lausanne, Switzerland

[5] Univ Lausanne, Dept Biochem, Epalinges, Switzerland

[6] Hop Univ Geneve, Serv Hematol, Geneva, Switzerland

[7] Pediat Clin Univ Milano Bicocca, Ctr Ric Tettamanti, Monza, Italy

[8] Debiopharm Int SA, Ch Messidor 5-7, CH-1002 Lausanne, Switzerland

[9] Univ Hosp Zurich, Clin Dermatol, Wagistr 14, CH-8952 Schlieren, Switzerland

[10] Phi Pharma SA, Pl Midi 36, CH-1950 Sion, Switzerland

来源：

CANCER CELL | 2019年 / 35卷 / 04期

基金：

瑞士国家科学基金会;

关键词：

CHRONIC MYELOID-LEUKEMIA; BETA-CATENIN; STEM-CELLS; C-MYC; BCR-ABL; TRANSCRIPTIONAL REGULATION; TRANSLOCATION PRODUCTS; SURVIVIN; PATHWAY; KINASE;

D O I：

10.1016/j.ccell.2019.03.005

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The BCR-ABL1 fusion protein is the cause of chronic myeloid leukemia (CML) and of a significant fraction of adult-onset B cell acute lymphoblastic leukemia (B-ALL) cases. Using mouse models and patient-derived samples, we identified an essential role for gamma-catenin in the initiation and maintenance of BCR-ABL1(+) B-ALL but not CML. The selectivity was explained by a partial gamma-catenin dependence of MYC expression together with the susceptibility of B-ALL, but not CML, to reduced MYC levels. MYC and gamma-catenin enabled B-ALL maintenance by augmenting BIRC5 and enforced BIRC5 expression overcame gamma-catenin loss. Since gamma-catenin was dispensable for normal hematopoiesis, these lineage- and disease-specific features of canonical Wnt signaling identified a potential therapeutic target for the treatment of BCR-ABL1(+) B-ALL.

引用

页码：649 / +

页数：25

共 50 条

[1] Chronic Myelogenous Leukemia, BCR-ABL1+
Vardiman, James W.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 132 (02) : 250 - 260
[2] MUC4 expression by immunohistochemistry is a specific marker for BCR-ABL1+ and BCR-ABL1-like B-lymphoblastic leukemia
Kaumeyer, Benjamin
Fidai, Shiraz
Sukhanova, Madina
Yap, Kai Lee
Segal, Jeremy
Raca, Gordana
Stock, Wendy
McNeer, Jennifer
Lager, Angela M.
Gurbuxani, Sandeep
LEUKEMIA & LYMPHOMA, 2022, 63 (06) : 1436 - 1444
[3] Identification and characterization of a murine model of BCR-ABL1+ acute B-lymphoblastic leukemia with central nervous system metastasis
Yu, Xiaozhuo
Zhang, Hua
Yuan, Meng
Zhang, Ping
Wang, Yang
Zheng, Mingzhe
Lv, Zhuangwei
Odhiambo, Woodvine Otieno
Li, Canyu
Liu, Chengcheng
Ma, Yunfeng
Ji, Yanhong
ONCOLOGY REPORTS, 2019, 42 (02) : 521 - 532
[4] BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia
Rizzotto, Lara
Saccenti, Elena
Sofritti, Olga
Daghia, Giulia
Volta, Eleonora
Caprini, Elisabetta
Lupini, Laura
Tammiso, Elisa
Bardi, Antonella
Lista, Enrico
Ciccone, Maria
Russo, Giandomenico
Negrini, Massimo
Cuneo, Antonio
Rigolin, Gian Matteo
LEUKEMIA & LYMPHOMA, 2013, 54 (09) : 2065 - 2067
[5] Blnk/Hdac9 maintains the nuclear localization of Foxo1 through supressing BCR-ABL1 kinase activity in BCR-ABL1+ B-cell acute lymphoblastic leukemia
Zhang, P.
Yu, X.
Yuan, M.
Wang, Y.
Ji, Y.
EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 324 - 324
[6] ABL1 Gene Deletion without BCR/ABL1 Rearrangement in B-Cell Acute Lymphoblastic Leukemia
Yu, Mingwei
Chang, Jason
Gao, Wenli
AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 : S6 - S7
[7] T-Cell acute lymphoblastic leukemia with a pinch of BCR-ABL1
Cortes, Jorge
De Keersmaecker, Kim
LEUKEMIA & LYMPHOMA, 2009, 50 (03) : 321 - 322
[8] BCR-ABL1+ Acute Myeloid Leukemia: Clonal Selection of a BCR-ABL1- Subclone as a Cause of Refractory Disease with Nilotinib Treatment
Neuendorff, Nina Rosa
Schwarz, Michaela
Hemmati, Philipp
Tuerkmen, Seval
Bommer, Christiane
Burmeister, Thomas
Doerken, Bernd
le Coutre, Philipp
Arnold, Renate
Westermann, Joerg
ACTA HAEMATOLOGICA, 2015, 133 (02) : 237 - 241
[9] Potent induction of apoptosis by givinostat in BCR-ABL1-positive and BCR-ABL1-negative precursor B-cell acute lymphoblastic leukemia cell lines
Yao, Chenjiao
Zhang, Guojuan
Walker, Alison
Zhao, Kevin Y.
Li, Ying
Lyu, Lei
Tang, Yan
Ru, Peng
Jones, Dan
Zhao, Weiqiang
LEUKEMIA RESEARCH, 2017, 60 : 129 - 134
[10] In BCR-ABL1 Positive B-Cell Acute Lymphoblastic Leukemia, Steroid Therapy Induces Hypofibrinogenemia
Buzzatti, Elisa
Forghieri, Fabio
Paterno, Giovangiacinto
Marchesi, Francesco
Sarlo, Chiara
Giglio, Fabio
Fracchiolla, Nicola
Sciume, Mariarita
Palmieri, Raffaele
Esposito, Fabiana
Guarnera, Luca
Mercante, Lisa
Pascale, Maria Rosaria
Mallegni, Flavia
Savi, Arianna
Forte, Vittorio
Maurillo, Luca
Buccisano, Francesco
Venditti, Adriano
Del Principe, Maria Ilaria
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (07)

← 1 2 3 4 5 →